SARAH FEARNOW: Open Payments
NPI 1275034209 · EATON RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 82 payments from 21 companies in 2025. Trend: 2023 $1,225 · 2024 $1,563 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $212 |
| PFIZER INC. | 11 | $211 |
| GlaxoSmithKline, LLC. | 10 | $182 |
| ViiV Healthcare Company | 8 | $176 |
| Lilly USA, LLC | 9 | $146 |
| ABBVIE INC. | 5 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Eisai Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
Products named: TRELEGY ELLIPTA, MOUNJARO, DOVATO, NURTEC ODT, Wegovy, Kerendia, VRAYLAR, ELIQUIS.
Industry payments across MI — which companies pay providers there.
